4-hydroxycyclophosphamide has been researched along with bilirubin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aschan, J; Barkholt, L; Hassan, M; Hassan, Z; Ringdén, O; Sjöö, F | 1 |
| Broberg, U; Griskevicius, L; Hassan, M; Hassan, Z; Kimby, E; Rane, A; Ståhle, L; Xie, H; Yasar, U | 1 |
1 trial(s) available for 4-hydroxycyclophosphamide and bilirubin
| Article | Year |
|---|---|
Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Aryl Hydrocarbon Hydroxylases; Bilirubin; Cyclophosphamide; Cytochrome P-450 CYP2B6; Female; Genotype; Hematologic Neoplasms; Humans; Liver; Male; Middle Aged; Models, Biological; Mutation; Oxidoreductases, N-Demethylating; Pharmacogenetics | 2006 |
1 other study(ies) available for 4-hydroxycyclophosphamide and bilirubin
| Article | Year |
|---|---|
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation.
Topics: Acetylcysteine; Adult; Area Under Curve; Bilirubin; Busulfan; Child; Cyclophosphamide; Female; Glutathione; Humans; Immunosuppressive Agents; Infant; Liver; Male; Middle Aged; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |